Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

AEFI and the pentavalent vaccine: looking for a composite picture.

Puliyel J.

Indian J Med Ethics. 2013 Jul-Sep;10(3):142-6. No abstract available.

2.

Safety of pentavalent vaccines.

Parthasarathy A.

Indian Pediatr. 2013 Dec;50(12):1162. No abstract available.

3.

Hexavalent vaccination and sudden death.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):59. No abstract available.

PMID:
15148983
4.

Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries.

Sreedhar S, Antony A, Poulose N.

Hum Vaccin Immunother. 2014;10(7):2062-5. doi: 10.4161/hv.28785.

5.

Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.

Dodoo AN, Renner L, van Grootheest AC, Labadie J, Antwi-Agyei KO, Hayibor S, Addison J, Pappoe V, Appiah-Danquah A.

Drug Saf. 2007;30(4):347-56.

PMID:
17408311
7.

Pentavalent vaccine and adverse events following immunization-untangling the misinterpretations.

Malik A.

Indian J Pediatr. 2014 Dec;81(12):1353-7. doi: 10.1007/s12098-013-1322-2. Epub 2014 Feb 7.

PMID:
24500059
8.

Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.

Gandhi DJ, Dhaded SM, Ravi MD, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Jayanth MV, Ravinuthala S, Sil A, Dhingra MS.

Hum Vaccin Immunother. 2016 Apr 2;12(4):946-54. doi: 10.1080/21645515.2015.1100779. Epub 2015 Nov 18.

9.

Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children.

Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LH, Halsey NA.

Vaccine. 2013 Dec 2;31(49):5909-14. doi: 10.1016/j.vaccine.2013.09.015. Epub 2013 Sep 19.

PMID:
24055354
10.
11.

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.

PMID:
24346596
12.

Sensorimotor polyneuropathy after hexavalent vaccination.

Gorczyca D, Schwirten U.

Scand J Infect Dis. 2014 Jan;46(1):66-8. doi: 10.3109/00365548.2013.831183. Epub 2013 Sep 20.

PMID:
24053264
13.
14.
15.

Immunogenicity and reactogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type B.

Shao PL, Lu CY, Hsieh YC; Taiwan Infanrix-049 Study Group, Bock HL, Huang LM.

J Formos Med Assoc. 2011 May;110(5):336-41. doi: 10.1016/S0929-6646(11)60050-8.

16.

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.

Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Chakravarty A, Parekh SS, Palkar S, Bhardwaj SH, Namjoshi GS, Verma V.

Hum Vaccin. 2011 Apr;7(4):451-7. Epub 2011 Apr 1.

PMID:
21403463
17.
18.

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

Lalwani SK, Agarkhedkar S, Sundaram B, Mahantashetti NS, Malshe N, Agarkhedkar S, Van Der Meeren O, Mehta S, Karkada N, Han HH, Mesaros N.

Hum Vaccin Immunother. 2017 Jan 2;13(1):120-127. doi: 10.1080/21645515.2016.1225639. Epub 2016 Sep 15.

Supplemental Content

Support Center